Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38...

4
Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen- Activated Protein Kinases and Retards Cell Death by Suppressing Endoplasmic Reticulum Stress-Mediated Apoptosis Authors: Cheol-Hee Choi, Yong-Keun Jung and Seon-Hee Oh Article title: Molecular Pharmacology (MOL #63495) SUPPLEMENTARY MATERIAL (Fig.1-3)

Transcript of Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38...

Page 1: Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.

Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells

is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards Cell

Death by Suppressing Endoplasmic Reticulum Stress-Mediated Apoptosis

Authors: Cheol-Hee Choi, Yong-Keun Jung and Seon-Hee Oh

Article title: Molecular Pharmacology (MOL #63495)

SUPPLEMENTARY MATERIAL (Fig.1-3)

Page 2: Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.

Supplementary Fig. 1

MCF10A

0 3 6 12 24

IRE1

Chop

β-actin

Caspase-4

17kDa

26 kDa

p19

Caspase-7

Activation of caspase-4 and induction of ER stress-related proteins in MCF-10A cells. Cells were treated with 250 µM capsaicin, harvested at indicated times, lyzed, and the lysates were subjected to immunoblotting. Capsaicin treatment induced ER stress through induction of IRE1, Chop, caspase-4, and caspase-7 activation.

Page 3: Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.

MCF-7 MDA-MB-231 MCF10A

0 0.5 1 3 6 12 24 0 0.5 1 3 6 12 24

Bcl2

Bid

0 0.5 1 3 6 12 24

β-actin

Bcl2 induction responds to capsaicin in malignant breast cells. To examine whether the less sensitivity to capsaicin in malignant breast cells is related with suppression of apoptosis, Expression of Bcl2 and Bid was analyzed Cells were treated with 250 µM capsaicin for up to 24 h, harvested, and lysed, and the Bcl2 and Bid were analyzed by immunoblotting. Antiapoptotic Bcl2 increased in a time-dependent manner in MCF-7 and MDA-MB-231cells. However, Bid remained constant. In MCF10A cells, Bcl2 and Bid downregulated respond to capsaicin (Lee et al., 2009)

Supplementary Fig. 2

Page 4: Journal title: Autophagy Induction by Capsaicin in Malignant Human Breast Cells is Modulated by p38 and ERK Mitogen-Activated Protein Kinases and Retards.

Fig. 3A

Supplementary Fig. 3

p-Akt

PD98059SB203580

Akt

Capsaicin - + - + - +

DMSO

β-actin

ERK2

LC3 II

p-ERK1/2

Effects of p38 and ERK on capsaicin-induced autophagy in MDA-MB-231 cells. (A) Cells were pretreated with SB203580 (10 μM) or PD98059 (10 μM) for 30 min before 250 µM capsaicin was added for 6 h. Cells were then harvested and lysed, and lysates were analyzed for p38, p-p38, Akt, p-Akt, ERK, p-ERK, and LC3II by immunoblotting. (B) Knockdown of the p38 gene blocked capsaicin-induced autophagy. Cells transfected with nonspecific (NS) siRNA or p38-specific siRNA were treated with capsaicin (250 µM) or DMSO for 6 h, and lysates were analyzed by immunoblotting. (C) Knockdown of the ERK gene enhanced the induction of autophagy. Cells transfected with nonspecific (NS) siRNA or ERK-specific siRNA were treated with capsaicin (250 µM) or DMSO for 6 h, and lysates were analyzed by immunoblotting. The p-Akt antibody used in the present study was not effective in MDA-MB-231 cells. Downregulation of p-p38 blocked LC3 conversion through downregulation of p-Akt. In contrast, downregulation of p-ERK enhanced LC3 conversion downstream of Akt.

Fig. 3B

NS siRNA

sip38siRNA

- + - + - +

control

p-Akt

Akt

β-actin

ERK2

LC3 II

p-ERK1/2

p-p38

p38

Fig. 3C

Capsaicin

NS siRNA

ERKsiRNA

- + - + - +

control

p-Akt

T-Akt

p-ERK1/2

ERK2

LC3I/ II

β-actin